Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Activator of G protein signaling 3 modulates prostate tumor development and progression.
The prevalent I686T human variant and loss-of-function mutations in the cardiomyocyte-specific kinase gene TNNI3K cause adverse contractility and concentric remodeling in mice.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Activator of G protein signaling 3 modulates prostate tumor development and progression.
Activator of G protein signaling 3 modulates prostate tumor development and progression. Carcinogenesis. 2019 12 31; 40(12):1504-1513.
View in:
PubMed
subject areas
Animals
Carcinogenesis
Cell Line, Tumor
Disease Progression
Guanine Nucleotide Dissociation Inhibitors
Heterografts
Humans
Male
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Nude
Prostatic Neoplasms
Signal Transduction
authors with profiles
Joe B Blumer